Cell motility and drug gradients in the emergence of resistance to chemotherapy.
about
Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms.Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapyChemotherapeutic Drugs Interfere with Gene Delivery Mediated by Chitosan-Graft-Poly(ethylenimine)Evolution of acquired resistance to anti-cancer therapy.Game theory in the death galaxy: interaction of cancer and stromal cells in tumour microenvironment.Evolutionary game theory for physical and biological scientists. II. Population dynamics equations can be associated with interpretations.Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.Ancient hot and cold genes and chemotherapy resistance emergence.Microfluidics as a new tool in radiation biology.Long range personalized cancer treatment strategies incorporating evolutionary dynamics.Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology.Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.Limiting the development of anti-cancer drug resistance in a spatial model of micrometastasesEvolutionary scalpels for dissecting tumor ecosystems.Exploiting ecology in drug pulse sequences in favour of population reductionMimicking Embedded Vasculature Structure for 3D Cancer on a Chip Approaches through Micromilling.Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy.Evolutionary Phase Transitions in Random Environments.A novel 3-D bio-microfluidic system mimicking in vivo heterogeneous tumour microstructures reveals complex tumour-stroma interactions.A Comparative Study of Cellular Uptake and Subcellular Localization of Doxorubicin Loaded in Self-Assemblies of Amphiphilic Copolymers with Pendant Dendron by MDA-MB-231 Human Breast Cancer Cells.Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma
P2860
Q27331155-E1986105-41CB-4489-B978-82E874BF51CBQ28544732-7DCC4F7B-93F4-467F-93C4-311B5D0780E7Q28547144-80153F86-513F-4CF3-AC5A-D9CFD7D294E6Q33758382-4184030D-0186-41B9-8533-2CD71EBDAD84Q33808741-3A296AD8-7408-4680-8050-AA8B480301EBQ33808755-9B805952-391F-4FB1-BC66-F8EC97A80CEFQ35931194-DC0FB26D-A9AC-4C3A-AC61-619069BE23AAQ35989910-1A8E1C76-E53D-47FD-A084-EFA7AB5AC14AQ36592718-DE035762-2C05-4953-B498-4314B5D6737AQ37358959-C2808E08-4914-4E23-A679-BA63361F2A6CQ37514977-ECAF4E85-49AC-4C05-8115-D2F49F154408Q38469320-57CA4A4E-AFD5-4504-9B22-1636480C403DQ38738084-83751062-3CB5-4BB2-9661-58C650AC21B4Q39030938-8FE00CF8-33AF-43FD-97AF-520443AFDBB7Q42695844-77181CBE-DC22-46B3-9528-4605E5299C1CQ47104048-9C45F86E-F63B-4E7E-A252-722DAD3A5A10Q47653913-70F6093A-E84A-46AD-BEAF-F51289350C29Q49206319-1E99EA75-8E73-4389-BB84-A23E7362F221Q51435074-F5516095-111C-47C0-A90A-125DA10862E2Q51504830-9768D63E-32BE-40AD-A4EB-04EB2A97DD51Q57814961-BE8C6CCF-ABD9-44F2-9335-B2471039839E
P2860
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
@en
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
@nl
type
label
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
@en
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
@nl
prefLabel
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
@en
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
@nl
P2093
P2860
P356
P1476
Cell motility and drug gradients in the emergence of resistance to chemotherapy.
@en
P2093
Guillaume Lambert
James C Sturm
Kevin Loutherback
Luis Estévez-Salmerón
Robert H Austin
Thea D Tlsty
P2860
P304
16103-16108
P356
10.1073/PNAS.1314385110
P407
P577
2013-09-17T00:00:00Z